Open AccessIs neutrophil gelatinase associated lipocalin useful in hepatitis C virus infection?
Author(s) -
Alessio Strazzulla,
Giuseppe Coppolino,
Concetta Di Fatta,
Francesca R. Giancotti,
Giuseppina D’Onofrio,
Maria Concetta Postorino,
Maria Mazzitelli,
Selma Valerie Mammone,
I. Gentile,
Laura Rivoli,
Eleonora Palella,
Tiziana Gravina,
Cristina Costa,
Vincenzo Pisani,
Vincenzo De Maria,
Giorgio Settimo Barreca,
Nadia Marascio,
Alfredo Focà,
Giorgio Fuiano,
Elio Gulletta,
Carlo Torti
Publication year - 2016
Publication title -
world journal of hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.913
H-Index - 55
ISSN - 1948-5182
DOI - 10.4254/wjh.v8.i19.815
Subject(s) - medicine , gastroenterology , lipocalin , renal function , hepatitis c virus , univariate analysis , fibrosis , immunology , multivariate analysis , virus
To evaluate neutrophil gelatinase associated lipocalin (NGAL) in patients infected by hepatitis C virus (HCV) before and during treatment with directly acting antivirals (DAAs).